Press Release

NIPPON EXPRESS HOLDINGS signs strategic partnership with US-based Cryoport

-Collaboration aimed at providing cryogenic transport services globally-

NIPPON EXPRESS HOLDINGS, INC. (President: Mitsuru Saito), has entered into a strategic partnership with Cryoport Systems (President: Jerrell W. Shelton; hereinafter "Cryoport"), a group company of the US-based specialized pharmaceutical carrier Cryoport, Inc., to provide the global pharmaceutical industry with cryogenic (-150°C or lower) transport services for cellular raw materials and regenerative medicine products.

27-Nov-23-1-1.jpg

("Dry Shipper" specialized container)

27-Nov-23-1-2.png

Headquartered in Nashville, Tennessee, Cryoport is a leading cold-chain company trusted by numerous pharmaceutical and regenerative medicine manufacturers and is a global provider of advanced technologies and high-quality services for biospecimen, cell, vaccine, regenerative medicine, biomaterial and other supply chains.

The NX Group has positioned the pharmaceutical industry as a key industry in the core business growth strategy outlined in the "NX Group Business Plan 2023: Dynamic Growth" and has acquired Good Distribution Practice (GDP) and CEIV Pharma certification for 34 business locations in 24 countries/regions as part of its determined efforts to put in place the requisite quality control systems and infrastructure. Since May 2022, the Group has been providing ultra-low temperature-controlled (-20°C to -85°C) logistics services to the pharmaceutical industry in Japan, and since June of that same year it has offered international air freight services using temperature-controlled containers capable of accommodating three temperature ranges: frozen transport (-20°C to 0°C) , refrigerated transport (2°C to 8°C), and constant-temperature transport (15°C to 25°C).

This strategic partnership brings together the NX Group's global network and Cryoport's advanced technologies to launch a new cryogenic (-150°C or lower) transport service that meets growing demand stemming from next-generation therapies. The new service will help the NX Group continue providing high-quality pharmaceutical logistics services globally to satisfy a wide range of customer needs.

[Service overview]

The NX Group remains committed to providing logistics support to customers in the global pharmaceutical industry by building a reliable and secure global pharmaceutical logistics platform and thereby contributing to the health of people around the world.